Orthocell: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 30 pages · English
Earlier from Orthocell
- Surgical Specialties Appointed as Exclusive Distributor
- Celgro Positive Safety and Performance in Human Hip Study
- 1st Patient Recruited in Ortho-ATI Shoulder Tendon Study
- Preliminary Final Report
- Ortho-ACI on Australian Register of Therapeutic Goods
Later from Orthocell
- Orthocell Granted CelGro Patent Protection in Canada
- Orthocell receives R&D tax incentive refund
- Orthocell Receives CE Mark for CelGro
- Orthocell Granted European Cartilage Regeneration Patent
- Orthocell Commences Treatment of Its 1,000th Patient
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell